OCULAR THERAPEUTIX, INC Public Float
OCULAR THERAPEUTIX, INC (OCUL) had Public Float of $1.60 billion as of 2025-06-30, per its 10-K filed 2026-02-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-05
- 2025-06-30: Entity Public Float $1.60B.
- 2024-06-30: Entity Public Float $1.06B.
- 2023-06-30: Entity Public Float $405.70M.
- 2022-06-30: Entity Public Float $284.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.60B 10-K · filed 2026-02-05 |
| 2024-06-30 | $1.06B 10-K · filed 2025-03-03 |
| 2023-06-30 | $405.70M 10-K · filed 2024-03-11 |
| 2022-06-30 | $284.00M 10-K · filed 2023-03-06 |
| 2021-06-30 | $1.08B 10-K · filed 2022-02-28 |
| 2020-06-30 | $478.00M 10-K · filed 2021-03-11 |
| 2019-06-28 | $169.00M 10-K · filed 2020-03-12 |
| 2018-06-29 | $224.00M 10-K · filed 2019-03-07 |
| 2017-06-30 | $221.00M 10-K · filed 2018-03-08 |
| 2016-06-30 | $88.00M 10-K · filed 2017-03-10 |
| 2015-06-30 | $371.00M 10-K · filed 2016-03-10 |
| 2014-12-31 | $305.00M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |